IL1B and hyperuricemia: Stigmasterol can decrease the levels of IL-17, TNF-α, and IL-1β in rheumatoid arthritis [44], can significantly reduce the plantar edema induced by MSU crystals, and can reduce the serum UA levels in hyperuricemia mice by inhibiting liver XOD activity [98, 99].